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Abstract We found that transcription of NOR-1 (neuron-de-
rived orphan receptor-1) is induced by the Ca2+/calmodulin-de-
pendent protein kinase IV (CaM-KIV) cascade by di¡erential
hybridization screening of a cDNA array using probes prepared
from SH-SY5Y cells infected with recombinant adenoviruses
expressing Ca2+/CaM-independent mutants of CaM-KIV and
CaM-K kinase (CaM-KK). Induction of NOR-1 mRNA expres-
sion by the CaM-KIV cascade was con¢rmed by RT-PCR.
Promoter analyses indicate that CaM-KIV cascade response
element is located between 3162 bp and 342 bp in the 1.7 kb
NOR-1 promoter containing triple cAMP response elements.
Disruption of each element signi¢cantly reduced the promoter
activity, indicating the direct transcriptional regulation of NOR-
1 by CaM-KIV cascade. 7 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Ca2þ/calmodulin-dependent protein kinases (CaM-Ks) con-
stitute a diverse group of enzymes that are involved in many
cellular responses and are activated by increasing intracellular
calcium concentrations. Previous studies have demonstrated
that two multifunctional CaM-Ks, CaM-KI and IV, are acti-
vated by phosphorylation of the Thr in their activation loop
by an upstream CaM-K kinase (CaM-KK). This strongly up-
regulates their catalytic activities (reviewed in [1,2]). This
CaM-K cascade has been demonstrated to be involved in
the activation of CaM-KIV in response to Ca2þ mobilization
in transfected COS-7 cells [3], Jurkat cells [4], and cultured
hippocampal neurons [5]. It has also been shown that the
CaM-KIV cascade is important in regulating Ca2þ-dependent
gene expression by phosphorylating transcription factors such
as cAMP response element (CRE) binding protein (CREB)
[6^8]. Furthermore, a recent study indicates that the phos-
phorylation of CREB is signi¢cantly attenuated in transgenic
mice carrying dominant negative CaM-KIV and that this dis-
rupts late phase long term potentiation [9]. The consolidation/
retention phase of hippocampus-dependent memory is also
impaired in these mice. In addition, mice de¢cient in CaM-
KIV show that the CaM-KIV-mediated pathway plays an
important role in the function and development of the cere-
bellum and is critical for male and female fertility [10^12].
Thus, the CaM-KIV pathway plays important roles in various
physiological events. Identifying genes that are induced by the
CaM-KIV cascade will further aid our understanding of the
physiological signi¢cance of this signaling pathway. Previous
studies have shown that the expression of several genes, in-
cluding c-fos [6], BDNF [13], and insulin [14], are induced by
the Ca2þ-dependent CaM-KIV-mediated pathway. Here we
performed di¡erential hybridization screening of a cDNA ar-
ray to identify CaM-KIV cascade-inducible genes. This ap-
proach revealed that NOR-1 (neuron-derived orphan recep-
tor-1), a member of the nuclear receptor family, is a target
gene of the CaM-KIV cascade.
2. Materials and methods
2.1. Plasmids and cDNAs
cDNAs of Ca2þ/CaM-independent mutant of CaM-KIV (CaM-
KIVc, 305HMDT to DEDD), CaM-KIV kinase-negative mutant
(CaM-KIVd, 305HMDT to DEDD, K71E), CaM-KK constitutively
active mutant (CaM-KKc, residues 1^434) and CaM-KK kinase-neg-
ative mutant (CaM-KKd, residues 1^434, K157A) in the pME18s
expression plasmids (DNAX Res. Inst. Inc.) were previously described
[3,15] (Fig. 1A). NOR-1 promoter and deletion mutants subcloned in
pGV-B plasmid (Wako) were constructed as previously described [16].
Mutagenesis of NOR-1 promoter was performed by Gene Editor site-
directed mutagenesis system (Promega) using mutagenic oligonucleo-
tides as follows: mtCRE1, 5P-GGGAGGAGGAGGGACTGGTAG-
CGTCCCATG-3P ; mtCRE2, 5P-AGCGTCCCATGGCCAGTCATT-
GACGTCTCG-3P ; mtCRE3, 5P-CATGGCGTCACATACTGGTCT-
CGCATTCCA-3P. Mutations were con¢rmed by nucleotide sequenc-
ing using an ABI 377 automated sequencer.
2.2. Cell culture, transfection and luciferase assay
COS-7 cells and SH-SY5Y cells were maintained as previously de-
scribed [17]. For transfection assay, COS-7 cells were plated at six-well
dishes on the day prior to transfection. COS-7 cells were transfected
with a luciferase reporter plasmid fused with the 1.7 kb NOR-1 pro-
moter together with either 0.8 Wg of empty vector (Mock) or 0.4 Wg of
CaM-KIV and CaM-KK expression plasmids as indicated using Lipo-
fectAmine PLUS reagent (Gibco-BRL) according to the manufactur-
er’s instructions. Cells were treated 16 h after transfection with or
without 1 WM ionomycin for another 8 h. After transfection, COS-7
cells were incubated in opti-MEM medium for 24 h, then harvested
with 150 Wl of lysis bu¡er (25 mM glycyl glycine, pH 7.8, 8 mM
MgSO4, 1 mM EDTA, 1% Triton X-100, 5% glycerol, 1 mM dithio-
threitol (DTT)), centrifuged at 15 000 rpm at 4‡C. For luciferase as-
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say, 50 Wl of supernatant was used. Luciferase activity was measured
using PicaGene LT7.5 Luminescence kit (Toyo Inki) and presented by
light units normalized with the total amount of protein.
2.3. Expression of CaM-KK or CaM-KIV mutants in SH-SY5Y
neuroblastoma cells using recombinant adenovirus infection
Recombinant adenoviruses carrying cDNAs of CaM-KK or CaM-
KIV were produced by Adeno-X Expression System (Clontech) as
previously described [17]. For virus infection, con£uent SH-SY5Y
cells in six-well culture plates were infected with viruses at a multi-
plicity of infection of 20 plaque-forming units/cell at 37‡C for 1 h.
After infection, viruses were aspirated and cells were further cultured
in RPMI medium containing 10% fetal bovine serum. The cells were
washed with phosphate-bu¡ered saline and lysed with 150 Wl of lysis
bu¡er (150 mM NaCl, 20 mM Tris^Cl pH 7.5, 10% glycerol, 2 mM
EDTA, 1% NP-40, 0.2 mM PMSF, 10 Wg/ml leupeptin, 10 Wg/ml
trypsin inhibitor, 1 WM microcystin-LR) on ice and then subjected
to 7.5% SDS^PAGE followed by Western blotting using either anti-
CaM-KIV antibody (1:4000, Transduction Lab.) or anti-CaM-KK
(1:2000, Transduction Lab.).
2.4. Protein kinase assay
Total cell lysates (8 Wg of protein) prepared as described above were
incubated at 30‡C for 5 min in 25 Wl of CaM-KIV kinase bu¡er
(50 mM HEPES, pH 7.5, 10 mM Mg(Ac)2, 1 mM dithiothreitol,
200 WM [Q-32P]ATP (1000^2000 cpm/pmol), 2 mM EGTA and
40 WM syntide-2 in the presence of 10 Wg/ml STO-609, a CaM-KK
inhibitor [17]. Protein kinase activity was measured as previously de-
scribed [18].
2.5. Di¡erential hybridization of cDNA microarray
Atlas cDNA expression neurobiology array (Clontech) was probed
with [K-32P]dCTP-labeled cDNA synthesized from total cellular RNA
that was isolated from the adenovirus-infected SH-SY5Y cells using
Trizol reagent (Gibco-BRL). The synthesis of radiolabeled probes,
hybridization and washing of the array ¢lters were carried out accord-
ing to the manufacturer’s protocol. Hybridization membranes were
then exposed to BioMAX MS ¢lm (Kodak) at 380‡C for 3 days.
2.6. RT-PCR analysis
For RT-PCR, 1 Wg of total RNA prepared from the adenovirus-
infected SH-SY5Y cells was reverse-transcribed to generate the ¢rst
strand cDNA using AMV reverse transcriptase (Life Science). Synthe-
sized cDNA was used as a template in PCR using Titanium Taq
polymerase (Clontech) with pairs of primers for c-fos (forward prim-
er: 5P-GCCTCTCTTACTACCACTCAC-3P, reverse primer: 5P-TAG-
TTGGTCTGTCTCCGCTTG-3P), G3PDH (forward primer: 5P-TGA-
AGGTCGGAGTCAACGGATTTGG-3P, reverse primer: 5P-CATG-
Fig. 1. Expression of the CaM-KIV cascade in SH-SY5Y cells infected with recombinant adenoviruses. A: Schematic representation of Ca2þ/
CaM-independent (CaM-KIVc and CaM-KKc) and kinase-negative (CaM-KIVd and CaM-KKd) mutants of CaM-KIV and CaM-KK. wt,
wild-type. B: Western blot analyses of the expression of CaM-KK and CaM-KIV mutants in adenovirus-infected SH-SY5Y cells, including
SH-SY5Y cells infected with an adenovirus containing the L-galactosidase gene (LacZ), by using either anti-CaM-KK (upper panel) or anti-
CaM-KIV (lower panel) antibodies. Arrowheads indicate exogenous CaM-KK (upper panel) and CaM-KIV (lower panel) proteins. C: Activa-
tion of CaM-KIVc by CaM-KKc in SH-SY5Y cells. Protein kinase activity of CaM-KIVc in adenovirus-infected cell extracts was measured in
the presence of EGTA and STO-609. Results represent the meanSS.D. of three experiments.
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TGGGCCATGAGGTCCACCAC-3P) and NOR-1 (forward primer:
5P-TAATCAGGAGCAGTGGAGCAGTGAG-3P, reverse primer:
5P-TAAGACACATCCTACCCTGGCGAAC-3P). PCR products were
then separated on a 2% agarose gel and stained with ethidium bro-
mide.
3. Results and discussion
To identify the gene(s) whose expression is induced by the
CaM-KK/CaM-KIV cascade, we generated recombinant ad-
enoviruses carrying the Ca2þ/CaM-independent form of CaM-
KIV (CaM-KIVc, 305HMDT-DEDD) [15], constitutively ac-
tive CaM-KK (CaM-KKc, 1^434) [3] and kinase-negative ver-
sions of equivalent mutants. After SH-SY5Y neuroblastoma
cells were infected with various combinations of recombinant
adenoviruses carrying the CaM-KIV and CaM-KK mutants,
the ability of the cell extracts to phosphorylate the syntide-2, a
peptide substrate that can be phosphorylated by CaM-KIV,
was measured in the absence of Ca2þ/CaM (Fig. 1C). This
protein kinase assay measuring CaM-KIV activity was per-
formed in the presence of STO-609, a speci¢c inhibitor of
CaM-KK [17], to avoid activation of CaM-KIV during the
kinase assay by contaminating CaM-KKc proteins in the cell
extract. As expected, no protein kinase activity was observed
in the extract of cells expressing the kinase-de¢cient CaM-
KIV mutant (CaM-KIVd) in combination with either the con-
stitutively active CaM-KK or the kinase-de¢cient CaM-KK
mutant (CaM-KKd). In contrast, the extract of cells express-
ing the Ca2þ/CaM-independent form of CaM-KIVc exhibited
a weak syntide-2 phosphorylation activity that was further
upregulated (8^10-fold) by co-expression of the constitutively
active CaM-KKc. This is consistent with the in vitro activa-
Fig. 2. The CaM-KK/CaM-KIV cascade induces NOR-1 gene expression. A: Induction of NOR-1 gene expression by CaM-KKc and CaM-
KIVc in SH-SY5Y was detected by di¡erential hybridization using a neurobiology cDNA expression array. 32P-labeled cDNA probes synthe-
sized from total cellular RNA prepared from SH-SY5Y cells expressing either CaM-KKc/CaM-KIVc (lower panel) or CaM-KKd/CaM-KIVd
(upper panel) as described in Fig. 1A were hybridized to two identical gene array membranes (Atlas Human Neurobiology Array, Clontech).
Each gene is represented by duplicate spots. Arrows indicate duplicate spots of the NOR-1 gene. B: RT-PCR analysis to detect NOR-1 tran-
scripts induced by CaM-KKc and CaM-KIVc. RT-PCR was performed using cDNA templates from total cellular RNA prepared from SH-
SY5Y cells expressing either CaM-KKc/CaM-KIVc (right lane) or CaM-KKd/CaM-KIVd (left lane). G3PDH and c-fos were also ampli¢ed as
a negative and a positive control, respectively.
Fig. 3. Induction of NOR-1 promoter activity by the CaM-KK/
CaM-KIV cascade. A: Transcriptional activity of the 1.7 kb NOR-1
promoter [16]. COS-7 cells were transfected with a luciferase report-
er plasmid fused with the 1.7 kb NOR-1 promoter together with ei-
ther 0.8 Wg of empty vector (Mock) or 0.4 Wg of CaM-KIV wild-
type and CaM-KK wild-type expression plasmids as indicated. Cells
were treated 16 h after transfection with vehicle (DMSO, open bar)
or 1 WM ionomycin (closed bar) for another 8 h followed by mea-
surement of luciferase activity. B: CaM-KKc and CaM-KIVc syner-
gistically induce NOR-1 promoter activation. COS-7 cells were
transfected with 1.7 kb NOR-1 reporter plasmid and 0.4 Wg of ex-
pression plasmid encoding CaM-KIVc and/or CaM-KKc as indi-
cated. Cells were treated 16 h after transfection with either vehicle
(DMSO, open bar) or 1 WM ionomycin (closed bar) for another 8 h
followed by measurement of luciferase activity. Results represent the
meanSS.D. of three independent transfections.
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tion of CaM-KIVc by CaM-KKc that has been demonstrated
previously [19]. The cell extracts were also subjected to West-
ern blot analysis using the anti-CaM-KK and anti-CaM-KIV
antibodies (Fig. 1B). The CaM-KIVc band was supershifted
on the SDS^PAGE gel when the CaM-KIVc-expressing cells
had been co-infected with CaM-KKc. No supershift of the
kinase-de¢cient CaM-KIV mutant (CaM-KIVd) co-infected
with CaM-KKc was observed while Thr196 is intact in this
mutant, which is a phosphorylation site for CaM-KK, indi-
cating that the hyper-autophosphorylation of CaM-KIV en-
hanced by CaM-KK results in the supershift. These results
indicate that CaM-KKc phosphorylates Thr196 of CaM-
KIVc in SH-SY5Y cells resulting in induction of CaM-KIVc
activity.
We prepared a 32P-labeled cDNA probe from total cellular
RNA isolated from adenovirus-infected SH-SY5Y cells ex-
pressing either CaM-KIVc/CaM-KKc or the kinase-de¢cient
CaM-KIVd/CaM-KKd mutants as a control. These probes
were used with identical neurobiology cDNA expression ar-
rays containing 588 genes, which did not include CaM-KIV
target genes such as c-fos and BDNF. We compared the pan-
els hybridized with the two di¡erent probes (Fig. 2A) and
found that expression of the NOR-1 gene was signi¢cantly
upregulated (arrowhead) by the expression of CaM-KKc/
CaM-KIVc. NOR-1 has previously been identi¢ed as a mem-
ber of the nuclear orphan receptor [20,21]. It is noteworthy
that we could not identify any other genes on this cDNA
array whose expressions were signi¢cantly induced by CaM-
KKc/CaM-KIVc.
To con¢rm the induction of NOR-1 by the CaM-KIV cas-
cade, we performed RT-PCR analysis using total cellular
RNA prepared from adenovirus-infected SH-SY5Y cells. As
shown in Fig. 2B, NOR-1 mRNA is signi¢cantly induced by
the expression of CaM-KKc/CaM-KIVc while G3PDH is not.
c-fos, a target gene of CaM-KIV, was also induced by CaM-
KKc/CaM-KIVc expression [6]. Notably, we found by RT-
PCR analysis that CaM-KKc/CaM-KIVc expression also
strongly induces the expression of Nur77 (NGFI-B), another
nuclear orphan receptor (data not shown).
To examine whether NOR-1 promoter activity is directly
Fig. 4. CREs in the NOR-1 promoter are the CaM-KIV cascade response elements. A: Mapping of CaM-KIV cascade response elements in
the NOR-1 promoter. Promoter activities of the various indicated deletion mutants of the NOR-1 promoter were analyzed as described in Fig.
3 in either transfected COS-7 cells with an empty vector (Mock, open bar) or COS-7 cells co-transfected with the CaM-KIVc and CaM-KKc
expression plasmids (closed bar). B: Mutagenesis analysis of CREs in the NOR-1 promoter. Promoter activities of 1.7 kb NOR-1 reporter genes
containing mutants of each putative CRE (mtCRE1, mtCRE2 and mtCRE3) were analyzed as described in Fig. 3 in either transfected COS-7
cells with an empty vector (Mock, open bar) or COS-7 cells co-transfected with the CaM-KIVc and CaM-KKc expression plasmids (closed
bar). Nucleotide sequence indicates the position of the putative CREs in the NOR-1 promoter [16]. The mutagenized nucleotides in each CRE
are also indicated. Results represent the meanSS.D. of three independent transfections.
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regulated by the CaM-KK/CaM-KIV cascade, we used a re-
porter gene fused with the 1.7 kb promoter of NOR-1 that has
previously been isolated [16]. COS-7 cells were co-transfected
with wild-type CaM-KIV and CaM-KK. As shown in Fig.
3A, stimulation of these cells with ionomycin to mobilize
Ca2þ strongly induced NOR-1 promoter activity. When the
cells were transfected with CaM-KIVc only, ionomycin stim-
ulation stimulated NOR-1 promoter activity four-fold, indi-
cating the presence of endogenous CaM-KK in COS-7 cells
(Fig. 3B). In the absence of Ca2þ mobilization, CaM-KIVc-
mediated transcriptional activation of the NOR-1 promoter
was enhanced (Vfour-fold) by co-transfection with CaM-
KKc. These observations correlate well with the activation
of CaM-KIVc by CaM-KKc in unstimulated SH-SY5Y cells
(Fig. 1C). Thus, the NOR-1 promoter is directly activated by
the CaM-KK/CaM-KIV cascade in intact cells.
We used reporter genes fused with various truncated NOR-
1 promoters to identify the CaM-KIV cascade response cis-
element in the promoter (Fig. 4A). COS-7 cells were trans-
fected with these reporters as well as with CaM-KIVc and
CaM-KKc. The CaM-KIV cascade-induced NOR-1 promoter
activity of the reporter gene truncated at 3162 bp was indis-
tinguishable from that of the 1.7 kb promoter. However, fur-
ther truncation of 120 bp signi¢cantly reduced the enhance-
ment of the promoter activity by the CaM-KIV cascade. This
indicates that the region between 3162 bp and 342 bp in the
NOR-1 promoter contains the CaM-KIV cascade response
element. Recently, three copies of putative CRE (CRE1,
CRE2 and CRE3) have shown to be located in this region
[16]. We tested whether these CREs are involved in the CaM-
KIV cascade by using 1.7 kb NOR-1 promoters containing
mutations in one of the CRE elements (Fig. 4B). Mutations
of any of the CREs (mtCRE1, mtCRE2 and mtCRE3) sig-
ni¢cantly impaired the promoter activity indicating that all
the CREs in the NOR-1 promoter are required for the full
induction of NOR-1 gene transcription by the CaM-KIV cas-
cade.
In summary, we identi¢ed NOR-1 as a CaM-KK/CaM-KIV
cascade-inducible gene by using di¡erential hybridization
screening with probes derived from adenovirus-infected cells
expressing Ca2þ/CaM-independent and inactive forms of
CaM-KK and CaM-KIV. This approach will be useful in
identifying other gene(s) whose transcription is induced by
the CaM-KK/CaM-KIV cascade as well as by other signal
transduction pathways. NOR-1 has been identi¢ed as a mem-
ber of the family of nuclear orphan receptor type transcription
factors [20,21]. A recent study has revealed that Nur77 (NGFI-
B), another nuclear orphan receptor, is also induced by the
CaM-KIV-mediated pathway in T-lymphocytes [22]. We con-
¢rmed such CaM-KIV-mediated induction of Nur77 tran-
scription by RT-PCR analysis in this study. The transcription
of Nur77 has been shown to be upregulated by CaM-KIV in a
MEF2-dependent manner [22]. We show here, however, that
NOR-1 transcription induced by CaM-KK/CaM-KIV cascade
is dependent on three CREs in the NOR-1 promoter. This
correlates well with previous studies indicating that CREB is
a target of CaM-KIV [6^8]. It has been suggested that the
physiological function of the nuclear orphan receptors is to
promote apoptosis [23]. In thymocytes, the induction of Nur77
is involved in negative selection, an event in thymic develop-
ment characterized by apoptosis of T-cells whose T-cell recep-
tor recognizes host tissue too strongly [24,25]. Further study
will be necessary to examine the involvement of the CaM-KIV
cascade in inducing the apoptosis of various cell types by
regulating the transcription of nuclear orphan receptor family
proteins.
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